Concordia

Biotech's Top 3 Stock Losers, and Winners, in 2016
Forbes
Mon, 01/2/17 - 12:03 pm
biotech
Concordia
Ophthotech
Cempra
Corbus Pharmaceuticals
CoLucid
AveXis
Specialty pharma will resume M&A, but cautiously: Report
Fierce Pharma
Sat, 06/11/16 - 10:31 am
specialty pharma
M&A
Valeant Pharmaceuticals
Concordia
Blacklisting Icahn: How Some Drug Companies Keep Out Activists
Bloomberg
Mon, 11/16/15 - 10:23 pm
Carl Icahn
activists
Concordia
Mylan Labs
Endo International
Teva Pharmaceutical